Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39 GBX | +0.52% | -2.50% | -3.70% |
May. 30 | Amberen, Brand of Alliance Pharma plc, Announces Launch of Amberen ENERGY MOOD SLEEP Gummies | CI |
May. 21 | Alliance Pharma plc Announces the Appointment of Nicholas John Sedgwick as Director | CI |
Sales 2023 * | 183M 235M | Sales 2024 * | 196M 251M | Capitalization | 211M 270M |
---|---|---|---|---|---|
Net income 2023 * | 17M 21.79M | Net income 2024 * | 18M 23.07M | EV / Sales 2023 * | 1.65 x |
Net Debt 2023 * | 92.2M 118M | Net Debt 2024 * | 69.1M 88.55M | EV / Sales 2024 * | 1.43 x |
P/E ratio 2023 * |
11.8
x | P/E ratio 2024 * |
11.9
x | Employees | 285 |
Yield 2023 * |
2.59% | Yield 2024 * |
2.65% | Free-Float | 88.24% |
1 day | +0.52% | ||
1 week | -2.50% | ||
Current month | +0.52% | ||
1 month | +15.73% | ||
3 months | -6.59% | ||
6 months | -1.14% | ||
Current year | -3.70% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Franklin
DFI | Director of Finance/CFO | 58 | 15-09-27 |
Jeyan Heper
COO | Chief Operating Officer | - | 23-01-31 |
Chief Tech/Sci/R&D Officer | 56 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 49 | 10-02-21 | |
Director/Board Member | 55 | 23-01-31 | |
Richard Jones
BRD | Director/Board Member | 58 | 18-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 39 | +0.52% | 2,654,623 |
24-05-31 | 38.8 | -0.77% | 1,001,727 |
24-05-30 | 39.1 | +2.89% | 690,401 |
24-05-29 | 38 | -1.68% | 1,578,851 |
Delayed Quote London S.E., June 03, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.70% | 267M | |
+15.37% | 41.97B | |
+20.80% | 22.34B | |
+14.89% | 15.25B | |
+16.53% | 14B | |
+49.78% | 12.06B | |
-11.09% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.55% | 5.49B |
- Stock Market
- Equities
- APH Stock